Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
Clinical trial NCT04225260 · COMPLETED
Trial details
- NCT number
- NCT04225260
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-27
- Primary completion
- 2021-04-12
- Enrollment
- 902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.